Sanofi launches VaxLine to support child vaccination in India during COVID

VaxLine is a tele-counselling facility with a toll-free number 1800 123 5011 that registers a parent’s missed call and allows a VaxLine health expert to return the call within 24 hours.

Published On 2020-06-18 06:16 GMT   |   Update On 2020-06-18 06:16 GMT
Advertisement
Mumbai: Sanofi Pasteur India, the vaccine division of Sanofi has announced the launch of VaxLine, a 24X7 helpline, that provides online and offline support to empower parents with detailed information on managing vaccination of their babies and children during and post the COVID-19 pandemic.

VaxLine is a tele-counselling facility with a toll-free number 1800 123 5011 that registers a parent's missed call and allows a VaxLine health expert to return the call within 24 hours.

Advertisement

The VaxLine website (https://bit.ly/VaxLine) addresses questions on interrupted vaccination and routine immunization including guidance on what parents can do till they re-start the vaccination schedule of their children.

Annapurna Das, Country Head India, Cluster Head South Asia, Sanofi Pasteur said, "The COVID-19 pandemic has changed the way we live our daily lives. Visits to the pediatricians have been interrupted. Disruption to routine immunizations, even for brief periods, could increase vulnerability of partially vaccinated children to vaccine-preventable diseases. VaxLine is our endeavour to address the needs of anxious parents on managing delayed immunization. While delayed vaccination is manageable, parents need to be aware that irrespective of schools re-opening, it is important that they plan catch-up vaccination as soon as it is feasible and safe."

As per the Ministry of Health and Family Welfare (MoHFW), immunization is an essential health service and should be continued even during the current pandemic. The Ministry has also issued guidelines on vaccination during COVID-19 period.

Read also: Sanofi to present growth opportunities, development strategy for Dupixent in type 2 inflammatory diseases

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News